Abstract
The potential medical Zn-1.7%Mg and Zn-1.7%Mg-0.2%Zr alloys strengthened using high-pressure torsion (HPT) were investigated in this work. HPT led to a significant refinement of the microstructure of both alloys with the formation of an ultrafine-grained structure (UFG). The average grain size after HPT was ~700–800 nm for both alloys. The formation of the UFG structure led to an increase in the ultimate tensile strength of up to 401 ± 16 and 482 ± 12 MPa for the Zn-1.7%Mg and Zn-1.7%Mg-0.2%Zr alloys, respectively. Additionally, a variation in ductility of the Zn-1.7%Mg and Zn-1.7%Mg-0.2%Zr alloys of up to 56.3 ± 16.9% and 4.4 ± 0.6%, respectively, was also observed, apparently due to textural changes. HPT led to a small increase in the degradation rate of the alloys after 1 day of incubation in the medium. However, an increase in the incubation period of up to 30 days slowed down the degradation process and leveled the difference between the initial and HPT-treated state of the alloys. HPT did not affect the cytotoxicity of the Zn-1.7%Mg-0.2%Zr alloy and contributed to the reduction of hemolysis. Thus, the processing of the Zn-1.7%Mg and Zn-1.7%Mg-0.2%Zr alloys using HPT accelerated their biodegradation without compromising their biocompatibility.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.